OCUPHIRE PHARMA INC. - COMMON STOCK
1,5800
21-июня-24 14:59:52
15 мин. задержка
Акции
-0,0200
-1,25%
Сегодняшний диапазон
1,5450 - 1,6450
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
06 июн 2024 06:57:22 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
01 апр 2024 06:14:52 Источник Nasdaq GlobeNewswire
-
08 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 фев 2024 15:10:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
05 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 янв 2024 15:10:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
30 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 ноя 2023 15:38:14 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
27 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
13 ноя 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
02 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 ноя 2023 15:52:46 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >